Biotechnology Stocks I Performance Guide: Syndax Pharmaceuticals, Inc. (SNDX)
SNDX has no dividends
Table and Chart of SNDX Performance
See what a $1,000 investment in SNDX is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| SNDX Returns | |
|---|---|
| Start Date | Apr-29-2016 |
| Start Price | $13.69 |
| End Date | Dec-01-2023 |
| End Price | $16.57 |
| # Prices | 93 |
| Min Date | Dec-31-2018 |
| Min Price | $4.45 |
| Max Date | Jan-31-2023 |
| Max Price | $28.70 |
| Total Return | 21.04% |
| Annualized Return | 2.49% |
| Current Value of $1,000 Purchase | $1,210 |
| Number Returns | 4,278 |
| Average Return | 60.40% |
| Number Profitable Returns | 3,065 |
| Percent Profitable Returns | 71.65% |
| Number Unprofitable Returns | 1,213 |
| Percent Unprofitable Returns | 28.35% |
| Profitable to Unprofitable Returns Ratio | 2.53 |
| SNDX Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $1,153,946,000 | Price to Sales | 12.67 |
| Earnings per Share | $-2.5900 |
| PE Ratio | None |
| PE to Growth Ratio | 0 |
| Price to Book | 3.213 |
| PRICE DATA | |
| 52 Week High | $29.86 |
| 52 Week Low | $11.21 |
| Analyst Target Price | $35.08 |
| 50-Day Moving Average | $13.91 |
| 200-Day Moving Average | $19.04 |
| FINANCIAL DATA | |
| Revenue per Share | $2.173 |
| Revenue | $126,576,000 |
| Profit Margin | 0% |
| Return on Equity | -0.505% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
SNDX Compare Returns with S&P 500
SNDX Trendline Chart